Healthcare

  According to our latest study on “ Pulmonary Devices Market Forecast to 2027– COVID-19 Impact and Global Analysis– by type, application, and end user,” the market was valued at US$  18,598.56 million in  2019 and is projected to reach US$  39,965.01 million  by 2027; it is expected to grow at a CAGR of 10.1% during 2020–2027. The report highlights trends prevailing in the global pulmonary devices market,and the drivers and hindrances pertaining to the market growth.   The global pulmonary devicesmarket,based on type, is segmented into therapeutic devices, consumables and accessories, diagnostic devices, and monitoring devices.The therapeutic devicessegment held the largest share of the market in 2019, and this growth is ascribed tothe increasing demand of inhalers and nebulizers by patients suffering with asthma and chronic obstructive pulmonary disorders. However, the consumables and accessoriessegment is estimated to register the highest CAGR during the forecast period. Also, the

  According to our new research study on “ Arterial Blood Gas Kits Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by product type, end-user,” the market is expected to reach US$ 773.01 million in 2028 from US$ 455.84 million in 2021 growing at a CAGR of 7.8% from 2021-2028. An arterial blood gas (ABG) is a blood test carried out by taking blood from an artery, rather than a vein. It is performed so that an accurate measurement of oxygen and carbon dioxide levels can be obtained, which then allows the patients oxygen to be delivered appropriately. The kit includes a needle protection sheath that cores the bevel and encapsulates the contaminated needle to prevent blood spatter. The integral safety clips on the syringe allows for audible and visual confirmation that the needle is secure. Syringes are available non-vented or with a rear vented system which automatically evacuates air out the back of the syringe as the blood fills during the draw. Arterial blood gas tests

  According to our new market research study on “ Near Infrared Imaging Market to 2027 – Global Analysis and Forecast – by product, applications and end user,” the market is expected to reach US$ 543.24 million by 2027 from US$ 395.14 million in 2019. The market is estimated to grow with a CAGR of 4.2% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.   Near infrared imaging uses light from 650 to 950 nm to detect any caused changes, accidents, or illnesses. It is an effective diagnostic tool for tissue imaging that is minimally invasive and non-ionizing. Blood or water, which are the main components of tissues, do not absorb NIR well thereby increasing the changes in illumination for internal structures. Since it offers faster resolution and is less harmless to patients, it is beneficial over other strategies. A rise in surgical procedures has increased the use of visualization equipment to perform th

  According to the latest study on  “ Vision Care Market Forecast to 2027 – COVID-19 Impact and Global Analysis –  by Product, and Distribution Channel, ” the market was valued  at US$  66,934.51 million in 2019 and is projected to reach US$  93,817.82 million by 2027; it is expected to grow at a CAGR of 4.5% during 2020–2027 . The report highlights the trends prevailing in the global vision care market, and drivers and deterrents pertaining to the market growth.   There are a wide variety of eye diseases prevalent across the globe, including cataract, glaucoma, and refractive errors. Most of the people have some sort of eye problems in their lifetime. As per the World Health Organization (WHO), around 2.2 billion people across the globe have a near or distance vision impairment. The leading cause of vision impairment is cataract (94 million) and uncorrected refractive errors (88.4 million). The other causes of vision impairment are glaucoma (7.7 million), corneal opacities (4.2 milli